Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene
© 2021 Santoliquido et al..
The oncogenic role of common fragile sites (CFS), focal and pervasive gaps in the cancer genome arising from replicative stress, remains controversial. Exploiting the TCGA dataset, we found that in most CFS the genes residing within the associated focal deletions are down-regulated, including proteins involved in tumour immune recognition. In a subset of CFS, however, the residing genes are surprisingly overexpressed. Within the most frequent CFS in this group, FRA4F, which is deleted in up to 18% of cancer cases and harbours the CCSER1 gene, we identified a region which includes an intronic, antisense pseudogene, TMSB4XP8. TMSB4XP8 focal ablation or transcriptional silencing elicits the overexpression of CCSER1, through a cis-acting mechanism. CCSER1 overexpression increases proliferation and triggers centrosome amplifications, multinuclearity, and aberrant mitoses. Accordingly, FRA4F is associated in patient samples to mitotic genes deregulation and genomic instability. As a result, cells overexpressing CCSER1 become sensitive to the treatment with aurora kinase inhibitors. Our findings point to a novel tumourigenic mechanism where focal deletions increase the expression of a new class of "dormant" oncogenes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Life science alliance - 4(2021), 8 vom: 02. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Santoliquido, Benedetta M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CCSER1 protein, human |
|---|
| Anmerkungen: |
Date Completed 08.12.2021 Date Revised 14.12.2021 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.26508/lsa.202101019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327347651 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327347651 | ||
| 003 | DE-627 | ||
| 005 | 20231225200603.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.26508/lsa.202101019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1091.xml |
| 035 | |a (DE-627)NLM327347651 | ||
| 035 | |a (NLM)34187875 | ||
| 035 | |a (PII)e202101019 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Santoliquido, Benedetta M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 Santoliquido et al. | ||
| 520 | |a The oncogenic role of common fragile sites (CFS), focal and pervasive gaps in the cancer genome arising from replicative stress, remains controversial. Exploiting the TCGA dataset, we found that in most CFS the genes residing within the associated focal deletions are down-regulated, including proteins involved in tumour immune recognition. In a subset of CFS, however, the residing genes are surprisingly overexpressed. Within the most frequent CFS in this group, FRA4F, which is deleted in up to 18% of cancer cases and harbours the CCSER1 gene, we identified a region which includes an intronic, antisense pseudogene, TMSB4XP8. TMSB4XP8 focal ablation or transcriptional silencing elicits the overexpression of CCSER1, through a cis-acting mechanism. CCSER1 overexpression increases proliferation and triggers centrosome amplifications, multinuclearity, and aberrant mitoses. Accordingly, FRA4F is associated in patient samples to mitotic genes deregulation and genomic instability. As a result, cells overexpressing CCSER1 become sensitive to the treatment with aurora kinase inhibitors. Our findings point to a novel tumourigenic mechanism where focal deletions increase the expression of a new class of "dormant" oncogenes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a CCSER1 protein, human |2 NLM | |
| 650 | 7 | |a Cell Cycle Proteins |2 NLM | |
| 700 | 1 | |a Frenquelli, Michela |e verfasserin |4 aut | |
| 700 | 1 | |a Contadini, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Bestetti, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Gaviraghi, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Barbieri, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a De Antoni, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Albarello, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Amabile, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Gardini, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Lombardo, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Doglioni, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Provero, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Soddu, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Cittaro, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Tonon, Giovanni |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Life science alliance |d 2018 |g 4(2021), 8 vom: 02. Aug. |w (DE-627)NLM286067536 |x 2575-1077 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2021 |g number:8 |g day:02 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.26508/lsa.202101019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2021 |e 8 |b 02 |c 08 | ||